Jump to content
Knowledge Hub

FDA - Platform Technology Designation Program for Drug Development

6th June 2024

FDA - Platform Technology Designation Program for Drug Development

This guidance provides details about the implementation of the platform technology designation program established by section 506K of the Federal Food, Drug, and Cosmetic Act (FD&C Act). 

View and Comment now

Back to News Archive

Share